CS271481B2 - Method of new tetrazole compounds production - Google Patents

Method of new tetrazole compounds production Download PDF

Info

Publication number
CS271481B2
CS271481B2 CS881180A CS118088A CS271481B2 CS 271481 B2 CS271481 B2 CS 271481B2 CS 881180 A CS881180 A CS 881180A CS 118088 A CS118088 A CS 118088A CS 271481 B2 CS271481 B2 CS 271481B2
Authority
CS
Czechoslovakia
Prior art keywords
tetrazol
formula
fluorophenyl
methyl
mmol
Prior art date
Application number
CS881180A
Other languages
Czech (cs)
English (en)
Other versions
CS118088A2 (en
Inventor
John J Wright
Sing-Yuen Sit
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of CS118088A2 publication Critical patent/CS118088A2/cs
Publication of CS271481B2 publication Critical patent/CS271481B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CS881180A 1987-02-25 1988-02-24 Method of new tetrazole compounds production CS271481B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1854287A 1987-02-25 1987-02-25
US07/151,513 US4897490A (en) 1987-02-25 1988-02-18 Antihypercholesterolemic tetrazole compounds

Publications (2)

Publication Number Publication Date
CS118088A2 CS118088A2 (en) 1989-08-14
CS271481B2 true CS271481B2 (en) 1990-10-12

Family

ID=26691223

Family Applications (1)

Application Number Title Priority Date Filing Date
CS881180A CS271481B2 (en) 1987-02-25 1988-02-24 Method of new tetrazole compounds production

Country Status (31)

Country Link
US (1) US4897490A (de)
JP (1) JP2603324B2 (de)
KR (1) KR960001203B1 (de)
CN (1) CN1026110C (de)
AT (1) AT395589B (de)
AU (1) AU1395088A (de)
BE (1) BE1002116A3 (de)
CA (1) CA1328268C (de)
CH (1) CH676848A5 (de)
CS (1) CS271481B2 (de)
DE (1) DE3805801C2 (de)
DK (1) DK174822B1 (de)
EG (1) EG18341A (de)
ES (2) ES2010246A6 (de)
FI (1) FI96601C (de)
FR (1) FR2612924B1 (de)
GR (1) GR1000472B (de)
HU (3) HU204038B (de)
IE (1) IE61619B1 (de)
IL (1) IL85529A (de)
IT (1) IT1216751B (de)
LU (1) LU87144A1 (de)
MX (1) MX9202847A (de)
MY (1) MY103214A (de)
NL (1) NL8800465A (de)
NO (1) NO169438C (de)
NZ (1) NZ223620A (de)
PT (1) PT86820B (de)
SE (1) SE503618C2 (de)
WO (1) WO1988006584A1 (de)
YU (1) YU36388A (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3741509A1 (de) * 1987-12-08 1989-06-22 Hoechst Ag Verfahren zur herstellung optisch aktiver 3-desmethylmevalonsaeurederivate sowie zwischenprodukte
GB2244706B (en) * 1988-02-18 1992-07-15 Bristol Myers Co Preparation of antihypercholesterolemic tetrazole intermediates
US4824959A (en) * 1988-02-18 1989-04-25 Bristol-Myers Company Intermediates for antihypercholesterolemic tetrazole compounds
US4870187A (en) * 1988-08-23 1989-09-26 Bristol-Myers Company Antihypercholesterolemic tetrazol-1-yl compounds
US5010205A (en) * 1988-08-23 1991-04-23 Bristol-Myers Company Antihypercholesterolemic tetrazol-1-yl intermediates
US4927944A (en) * 1988-08-25 1990-05-22 Bristol-Myers Company Antihypercholesterolemic nitrile compounds
FI94339C (fi) 1989-07-21 1995-08-25 Warner Lambert Co Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
US5413935A (en) * 1991-04-24 1995-05-09 E. R. Squibb & Sons, Inc. Process for selecting an enantiomer of a hydroxy lactone using pseudomonas lipase
US5134155A (en) * 1991-08-08 1992-07-28 Ortho Pharmaceutical Corporation Tetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydrocycloheptapyrazole compounds and their use as HMG-coA reductase inhibitors
US5986095A (en) * 1992-01-06 1999-11-16 E.R. Squibb & Sons, Inc. Enantioselective preparation of halophenyl alcohols and acylates
US5278313A (en) * 1992-03-27 1994-01-11 E. R. Squibb & Sons, Inc. Process for the preparation of 1,3-dioxane derivatives useful in the preparation of HMG-COA reductase inhibitors
US5324662A (en) * 1992-05-15 1994-06-28 E. R. Squibb & Sons, Inc. Stereoselective microbial or enzymatic reduction of 3,5-dioxo esters to 3-hydroxy-5-oxo, 3-oxo-5-hydroxy, and 3,5-dihydroxy esters
US5284957A (en) * 1992-09-03 1994-02-08 Eli Lilly And Company Excitatory amino acid receptor antagonists
JPH06329679A (ja) * 1993-01-20 1994-11-29 Nissan Chem Ind Ltd 光学活性β−アミノアルコキシボラン錯体
CA2137049A1 (en) * 1993-12-15 1995-06-16 John K. Thottathil Amino acid salts of and methods for preparing antihypercholesterolemic tetrazole compounds
DE19714343A1 (de) 1997-04-08 1998-10-15 Bayer Ag Chromatographische Enantiomerentrennung von Lactonen
JP2001526256A (ja) * 1997-12-19 2001-12-18 ワーナー−ランバート・エクスポート・リミテッド １，３−ジオールの合成方法
DE10216967A1 (de) * 2002-04-16 2003-11-13 Bayer Ag Verfahren zur Herstellung spezieller aromatischer Aldehyde
WO2009009152A1 (en) * 2007-07-12 2009-01-15 Teva Pharmaceutical Industries Ltd. Rosuvastatin intermediates and their preparation
KR101681041B1 (ko) 2015-07-15 2016-12-22 경북대학교병원 ＥＲＲγ 비활성화 리간드로서의 신규한 방향족 고리 화합물 유도체

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4160100A (en) * 1973-03-23 1979-07-03 American Home Products Corporation Oxamic acid derivatives
US4054666A (en) * 1973-03-23 1977-10-18 American Home Products Corporation Compositions and methods of treating immediate hypersensitivity reactions with thiazolyl oxamic acid derivatives
US4013647A (en) * 1976-03-23 1977-03-22 American Home Products Corporation Morpholine containing tetrazole-5-carboxamide derivatives
JPS53147073A (en) * 1977-05-24 1978-12-21 Sankyo Co Ltd Mevalonolactone derivatives
US4375475A (en) * 1979-08-17 1983-03-01 Merck & Co., Inc. Substituted pyranone inhibitors of cholesterol synthesis
US4567289A (en) * 1979-08-17 1986-01-28 Merck & Co., Inc. Substituted pyranone inhibitors of cholesterol synthesis
NZ194557A (en) * 1979-08-17 1984-09-28 Merck & Co Inc Substituted pyranone derivatives;dihydroxy acids therefrom;pharmaceutical compositions
EP0068038B1 (de) * 1981-06-29 1985-09-25 Merck & Co. Inc. (+)-(4R.6S)-(E)-6-(2-(4'-Fluor-3,3',5-trimethyl-(1,1'-biphenyl)-2-yl)ethenyl)-3,4,5,6-tetrahydro-4-hydroxy-2H-pyran-2-on, Verfahren zu seiner Herstellung und eine diese Verbindung enthaltende pharmazeutische Zusammensetzung
DE3153060D2 (en) * 1981-12-10 1984-10-04 Willy Bayer Internal combustion engine
US4739073A (en) * 1983-11-04 1988-04-19 Sandoz Pharmaceuticals Corp. Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof
WO1984002131A1 (fr) * 1982-11-22 1984-06-07 Sandoz Ag Produits analogues de mevalolactone et leurs derives, leurs procedes de production, compositions pharmaceutiques les contenant ainsi que leur utilisation en tant que produits pharmaceutiques
PT77996B (en) * 1983-01-24 1986-05-30 Sandoz Sa Process of the preparations of mevalonelactone analogs and derivatives thereof and of pharmaceutical compositions containing them
CA1327360C (en) * 1983-11-14 1994-03-01 William F. Hoffman Oxo-analogs of mevinolin-like antihypercholesterolemic agents
US4613610A (en) * 1984-06-22 1986-09-23 Sandoz Pharmaceuticals Corp. Cholesterol biosynthesis inhibiting pyrazole analogs of mevalonolactone and its derivatives
AU573368B2 (en) * 1984-06-22 1988-06-02 Sandoz Ag Pyrazole analogs of mevalonolactone and derivatives thereof, process for their production and their use
US4668794A (en) * 1985-05-22 1987-05-26 Sandoz Pharm. Corp. Intermediate imidazole acrolein analogs
US4621099A (en) * 1985-09-23 1986-11-04 Usv Pharmaceutical Corporation Polyene compounds useful in the treatment of allergic responses
US4681893A (en) * 1986-05-30 1987-07-21 Warner-Lambert Company Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis
US4678806A (en) * 1986-09-02 1987-07-07 Merck & Co., Inc. Prodrugs of antihypercholesterolemic compounds

Also Published As

Publication number Publication date
KR880009947A (ko) 1988-10-06
MX9202847A (es) 1992-06-30
NZ223620A (en) 1991-07-26
HU203329B (en) 1991-07-29
HU900669D0 (en) 1990-06-28
CH676848A5 (de) 1991-03-15
HUT47259A (en) 1989-02-28
HU204516B (en) 1992-01-28
ES2010246A6 (es) 1989-11-01
FR2612924B1 (fr) 1991-01-11
FI96601B (fi) 1996-04-15
DK97288A (da) 1988-08-26
LU87144A1 (fr) 1988-09-20
JP2603324B2 (ja) 1997-04-23
IL85529A (en) 1993-01-31
ATA46188A (de) 1992-06-15
PT86820A (pt) 1989-02-28
ES2026746A6 (es) 1992-05-01
US4897490A (en) 1990-01-30
JPH01502269A (ja) 1989-08-10
NL8800465A (nl) 1988-09-16
FR2612924A1 (fr) 1988-09-30
SE503618C2 (sv) 1996-07-15
HU896737D0 (en) 1990-02-28
SE8800638L (sv) 1988-09-21
YU36388A (en) 1989-10-31
PT86820B (pt) 1995-03-01
FI96601C (fi) 1996-07-25
DK174822B1 (da) 2003-12-08
AU1395088A (en) 1988-09-26
FI880869A0 (fi) 1988-02-24
IT8819525A0 (it) 1988-02-24
GR1000472B (el) 1992-07-30
BE1002116A3 (fr) 1990-07-10
IT1216751B (it) 1990-03-08
AT395589B (de) 1993-01-25
DE3805801C2 (de) 2001-03-01
FI880869A7 (fi) 1988-08-26
CA1328268C (en) 1994-04-05
WO1988006584A1 (en) 1988-09-07
IL85529A0 (en) 1988-08-31
HU204038B (en) 1991-11-28
NO169438C (no) 1992-06-24
SE8800638D0 (sv) 1988-02-24
IE880501L (en) 1988-08-25
CN88100911A (zh) 1988-09-28
NO880809L (no) 1988-08-26
CN1026110C (zh) 1994-10-05
IE61619B1 (en) 1994-11-16
DK97288D0 (da) 1988-02-24
GR880100101A (en) 1988-12-16
DE3805801A1 (de) 1988-09-08
KR960001203B1 (ko) 1996-01-24
EG18341A (en) 1993-08-30
CS118088A2 (en) 1989-08-14
NO880809D0 (no) 1988-02-24
NO169438B (no) 1992-03-16
MY103214A (en) 1993-05-29

Similar Documents

Publication Publication Date Title
CS271481B2 (en) Method of new tetrazole compounds production
US5011947A (en) Antihypercholesterolemic alkylene compounds
SE503618C3 (sv) Antihyperkolesterolemiska tetrazolföreningar
US5110940A (en) Antihypercholesterolemic tetrazole compounds
US4870187A (en) Antihypercholesterolemic tetrazol-1-yl compounds
FI96600B (fi) Välituotteina käyttökelpoisia tetratsoliyhdisteitä
AU601264B2 (en) Antihypercholesterolemic tetrazole compounds
GB2202846A (en) 1,1-diphenyl-2tetrazolyl-ethene derivatives
US5010205A (en) Antihypercholesterolemic tetrazol-1-yl intermediates
US5068346A (en) Tetrazole compounds
EP0658550A2 (de) Aminosäuresalze von antihypercholesterolemischen Tetrazolverbindungen und Verfahren zu ihrer Herstellung
US5070206A (en) Tetrazol-1-yl containing intermediates
EP0355846A2 (de) Antihypercholesterolemische Nitrilverbindungen
US4939265A (en) Intermediates and process for the preparation of antihypercholesterolemic tetrazole compounds
US4981991A (en) Antihypercholesterolemic nitrile compounds
FI96602B (fi) Menetelmä terapeuttisesti aktiivisten tetratsolijohdannaisten valmistamiseksi
IE880848L (en) Unsaturated oxyranylbenzene derivatives
NO178190B (no) 3,3-bis-(eventuelt substituert)-fenyl-2-(1-metyl-1H-tetrazol-5-yl)-1-propenal
DD279880A5 (de) Verfahren zur herstellung neuer tetrazolverbindungen

Legal Events

Date Code Title Description
IF00 In force as of 2000-06-30 in czech republic
MK4A Patent expired

Effective date: 20080224